相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c-Myc mice
Ningning Liu et al.
HEPATOLOGY (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis
Jing Han et al.
CANCER LETTERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway
Kazuya Fukasawa et al.
ONCOGENE (2021)
Arginine Signaling and Cancer Metabolism
Chia-Lin Chen et al.
CANCERS (2021)
Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)
Aaron C. Tan
THORACIC CANCER (2020)
Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review
Houssam Al-Koussa et al.
CANCER CELL INTERNATIONAL (2020)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
Milind D. Chalishazar et al.
CLINICAL CANCER RESEARCH (2019)
Oncoprotein CIP2A promotes the disassembly of primary cilia and inhibits glycolytic metabolism
Ae Lee Jeong et al.
EMBO REPORTS (2018)
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Jasmine Chong et al.
NUCLEIC ACIDS RESEARCH (2018)
mTOR signalling and cellular metabolism are mutual determinants in cancer
Dirk Mossmann et al.
NATURE REVIEWS CANCER (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers
Jeff Charles Kremer et al.
CELL REPORTS (2017)
Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53
Takafumi Miyamoto et al.
SCIENCE ADVANCES (2017)
The role of CIP2A in cancer: A review and update
Saiedeh Razi Soofiyani et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Xuewen Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion
Saleh Al-Dimasi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity
Bernadette Carroll et al.
ELIFE (2016)
CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer
Bo Peng et al.
MOLECULAR BIOSYSTEMS (2015)
Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands
Pradip De et al.
ONCOTARGET (2014)
Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
Anchit Khanna et al.
CANCER RESEARCH (2013)
Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction
Yan Long et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Senescence Sensitivity of Breast Cancer Cells Is Defined by Positive Feedback Loop between CIP2A and E2F1
Anni Laine et al.
CANCER DISCOVERY (2013)
Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation
D. P. Mathiasen et al.
ONCOGENE (2012)
CIP2A Is Associated with Human Breast Cancer Aggressivity
Christophe Come et al.
CLINICAL CANCER RESEARCH (2009)
CIP2A inhibits PP2A in human malignancies
Melissa R. Junttila et al.
CELL (2007)
分享论文
